Morgan Stanley Anika Therapeutics, Inc. Transaction History
Morgan Stanley
- $1.27 Trillion
- Q2 2024
A detailed history of Morgan Stanley transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 501,988 shares of ANIK stock, worth $12.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
501,988
Previous 701,732
28.46%
Holding current value
$12.3 Million
Previous $17.8 Million
28.66%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding ANIK
# of Institutions
118Shares Held
11.8MCall Options Held
2.7KPut Options Held
5K-
Trigran Investments, Inc.2.14MShares$52.4 Million5.66% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$39.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA790KShares$19.4 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX749KShares$18.4 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny598KShares$14.7 Million0.03% of portfolio
About Anika Therapeutics, Inc.
- Ticker ANIK
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,599,900
- Market Cap $358M
- Description
- Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...